3 Penny Stocks With Market Caps Up To $3B

Over the last 7 days, the U.S. market has dropped 1.6%, but it is up 12% over the past year, with earnings forecasted to grow by 17% annually. In light of these conditions, identifying stocks with robust financials and clear growth potential can be rewarding, especially when considering smaller or less-established companies often referred to as penny stocks. Despite their somewhat outdated name, penny stocks remain relevant for investors seeking opportunities in companies that show promise and stability; this article explores three such options worth considering.

Underneath we present a selection of stocks filtered out by our screen.

Clover Health Investments (CLOV)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Clover Health Investments, Corp. offers Medicare Advantage plans in the United States and has a market cap of approximately $2.54 billion.

Operations: The company generates revenue primarily from its Insurance segment, which amounts to $2.48 billion.

Market Cap: $2.54B

Clover Health Investments has shown significant financial improvement, reporting a net income of US$28 million for Q2 2026 compared to a loss the previous year. The company has raised its full-year revenue guidance to between US$2.92 billion and US$3 billion. Despite being unprofitable in the past, Clover now maintains positive free cash flow with a sufficient cash runway for over three years. Recent strategic initiatives include expanding Medicare Advantage offerings and leveraging its Clover Assistant technology to enhance clinical decision-making, while new board appointments strengthen governance with expertise in healthcare policy and business strategy.

• Dive into the specifics of Clover Health Investments here with our thorough balance sheet health report.
• Assess Clover Health Investments' future earnings estimates with our detailed growth reports.

Treace Medical Concepts (TMCI)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Treace Medical Concepts, Inc. is a medical technology company that designs, manufactures, and markets medical devices in the United States with a market cap of $266.64 million.

Operations: The company's revenue is derived entirely from its operations in designing, manufacturing, and marketing medical devices, totaling $205.31 million.

Market Cap: $266.64M

Treace Medical Concepts, Inc. has been actively presenting clinical data from its studies at major conferences, highlighting advancements in bunion correction and joint fixation technologies. Despite recent product innovations and a stable weekly volatility of 8%, the company remains unprofitable with increasing losses over the past five years. Its short-term assets of US$120.5 million cover both short- and long-term liabilities, but debt levels have risen significantly to an 87.9% debt-to-equity ratio over five years. The company's cash runway is sufficient for more than a year based on current free cash flow trends, providing some financial stability amidst ongoing challenges in achieving profitability.

• Jump into the full analysis health report here for a deeper understanding of Treace Medical Concepts.
• Examine Treace Medical Concepts' earnings growth report to understand how analysts expect it to perform.

Xtra-Gold Resources (XTGR.F)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Xtra-Gold Resources Corp. is a gold exploration company operating in Ghana with a market cap of $83.42 million.

Operations: Xtra-Gold Resources Corp. has not reported any revenue segments.

Market Cap: $83.42M

Xtra-Gold Resources Corp., operating debt-free with a market cap of US$83.42 million, has demonstrated robust earnings growth, reporting a net income of US$1.2 million for Q2 2026, up from US$0.577 million the previous year. Despite being pre-revenue with no significant revenue streams, the company's earnings have grown significantly at 65.7% over the past year and 40.2% annually over five years, though it lags behind industry growth rates. The management team is experienced with an average tenure of 14 years, and its short-term assets (US$18.7M) comfortably cover liabilities (US$1.5M).

• Get an in-depth perspective on Xtra-Gold Resources' performance by reading our balance sheet health report here.
• Gain insights into Xtra-Gold Resources' past trends and performance with our report on the company's historical track record.

Make It Happen

• Get an in-depth perspective on all 326 US Penny Stocks by using our screener here.
• Interested In Other Possibilities? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com